Plus Therapeutics Granted U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda for the Treatment of Leptomeningeal Metastases in Patients with Lung Cancer
March 06, 2025 07:30 ET
|
Plus Therapeutics Inc.
Plus Therapeutics Granted U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda for the Treatment of Leptomeningeal Metastases in Patients with L
PD-1 Inhibitor Drugs Market Surges with Expanding Immunotherapy Applications, Set to Cross $201.5 Billion by 2035 | Latest Report by TMR
March 04, 2025 07:09 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. – , March 04, 2025 (GLOBE NEWSWIRE) -- The Global PD-1 Inhibitor Drugs Market, valued at US$ 41.4 billion in 2024, is set for...
Cancer Biopsy Market Size is Expected to Reach USD 60.92 Billion by 2033, Growing at a CAGR of 7.81%: Straits Research
January 20, 2025 10:35 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, Jan. 20, 2025 (GLOBE NEWSWIRE) -- A biopsy is a procedure where a small amount of tissue is extracted for examination under a microscope. In the case of a core biopsy,...
Candel Therapeutics Announces $80 Million Proposed Public Offering
December 12, 2024 16:51 ET
|
Candel Therapeutics
NEEDHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (“Candel”) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological...
Lung Cancer Therapeutics Market Analysis by treatment into Chemotherapy, Targeted Therapy, Radiotherapy and Biological Therapy Through 2034 | Future Market Insights, Inc.
November 27, 2024 09:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The Lung Cancer Therapeutics Market 2024 to 2034 is expected to experience a substantial increase in size, growing from USD 37.5 billion in 2024 to USD...
Liquid Biopsy Market Size to Worth USD 28.84 Billion by 2033 | Straits Research
November 21, 2024 09:55 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, Nov. 21, 2024 (GLOBE NEWSWIRE) -- "Liquid biopsy" isolates and detects circulating nucleic acids (DNA or RNA), exosomes, and circulating tumor cells to diagnose primary...
Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 13, 2024 16:05 ET
|
Immuneering Corporation
Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates
BC Organizations Launch In-Home Danger Radon Gas Public Awareness Campaign
November 04, 2024 08:00 ET
|
British Columbia Real Estate Association
Vancouver, Nov. 04, 2024 (GLOBE NEWSWIRE) -- November is Radon Action Month, and the BC Real Estate Association (BCREA), BC Lung Foundation, and Real Estate Foundation of BC are announcing the...
WAKE RADIOLOGY TO HOST LUNG CANCER SCREENING EVENT SATURDAY, NOVEMBER 9
October 31, 2024 09:40 ET
|
Wake Radiology UNC Health Rex
Raleigh, N.C., Oct. 31, 2024 (GLOBE NEWSWIRE) -- On Saturday, November 9, Wake Radiology UNC Health Rex, in partnership with the American College of Radiology, is participating in National Lung...
New Treatments, Novel Research Drive Better Survival Rates for Canadians with Lung Cancer, Offering Hope to Thousands: Lung Health Foundation
October 31, 2024 08:26 ET
|
Lung Health Foundation
New treatments and novel research are driving better survival rates for Canadians with Lung Cancer, offering hope to thousands of patients.